RNA editing describes the changes that take place in the RNA sequence after transcription is completed. Examples include modification of cytosine to uracil or of adenine to isoleucine by deamination, ...

On Tuesday, 11 March 2025, Editas Medicine (NASDAQ: EDIT) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic focus on advancing in vivo CRISPR gene editing ...

On Wednesday, 14 May 2025, Editas Medicine (NASDAQ:EDIT) presented at the BofA Securities 2025 Healthcare Conference, emphasizing its strategic pivot towards in vivo gene editing. The company aims to ...